Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.
Bruce A Samuels, Samit M Shah, R Jay Widmer...
https://pubmed.ncbi.nlm.nih.gov/37704315/Actively Recruiting
Led by Baylor Research Institute · Updated on 2026-05-05
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating coronary flow reserve CFR, index of microcirculatory resistance IMR, and related measurements in patients with angina but without significant coronary artery disease. This prospective, single-arm study involves patients undergoing coronary angiography for angina with non-obstructive coronary artery disease ANOCA or INOCA. The goal is to understand changes in these coronary function measures before and after intracoronary nitroglycerin administration. Participants will undergo coronary reactivity testing CRT in the left anterior descending and right coronary arteries. First, measurements such as CFR, IMR, distal coronary to aortic pressure ratio PdPa, transit times, resting full-cycle ratio RFR, fractional flow reserve FFR, and resistive reserve ratio RRR will be taken without intracoronary nitrates. Then, a dose of 200-500 mcg of intracoronary nitroglycerin will be administered and the same measurements repeated to observe changes. During the study, approximately 50 patients will be monitored during their cardiac catheterization procedure. Data will be collected intraoperatively to compare coronary function variables before and after nitrate administration. Researchers will analyze primary outcomes focusing on CFR changes and secondary outcomes including IMR, Pd, Pa, RRR, and transit times. The study aims to provide detailed insight into coronary microcirculatory function in this patient population.
CONDITIONS
Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing
B
Bonnie Ostergren
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Baylor Research Institute
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | CRT with and without nitrate (Investigational) | Current Guideline-Based Diagnostic Pathway |
|---|---|---|
| What it is | Coronary reactivity testing (CRT) examines the function of both large and small coronary arteries by administering vasoactive medications, first without and then with intracoronary nitrate. Measures such as coronary flow reserve (CFR), index of microvascular resistance (IMR), and other parameters are evaluated before and after the nitrate is given. | Guidelines recommend a stepwise approach for patients with suspected ANOCA or INOCA, starting with non-invasive testing (such as stress imaging or coronary CT angiography) followed by invasive functional coronary testing to identify microvascular or vasospastic angina in selected cases. |
| Role in the study | Used as the investigational diagnostic procedure for assessing coronary vascular function in patients evaluated for unexplained angina symptoms. | Serves as the established diagnostic approach to clarify the cause of angina symptoms in patients without obstructive coronary artery disease. |
| Primary use | Detects abnormalities in coronary artery function, including microvascular or vasospastic angina, by quantifying vessel responses to nitrates. | Identifies or excludes microvascular and vasospastic causes of angina in individuals with unobstructed coronary arteries, guiding management decisions. |
| How it is performed | CRT is done invasively by passing a catheter into the coronary arteries. Baseline vessel measurements are obtained, followed by administration of 200-500 mcg of intracoronary nitrate, with repeat measurements to assess changes in coronary flow and resistance. | Non-invasive methods are used first, such as stress imaging or CT angiography. Invasive coronary reactivity testing may follow if indicated, using vasodilators (like nitrates or acetylcholine) to assess vessel function during cardiac catheterization. |
| Evidence status | Ongoing clinical investigation; results for this diagnostic approach in this population are not yet established. | Supported by clinical guidelines and expert consensus, with established use in specialized practice for diagnosing the mechanism of chest pain in non-obstructive disease. |
| Important limitations | CRT is invasive and may not be widely available. There is procedural risk and some uncertainty regarding the clinical impact of specific findings in different patient subgroups. | Current pathways may involve stepwise testing and may still miss microvascular or vasospastic contributors in some patients. Not all tests are universally accessible, and specialized expertise is required. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for consent and eligibility assessment
Duration - Single day procedure
Participants undergo coronary reactivity testing first without intracoronary nitrates followed by administration of intracoronary nitrates and repeat testing to assess coronary function.
1 procedure visit (in-person) in the cardiac catheterization laboratory
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Bruce A Samuels, Samit M Shah, R Jay Widmer...
https://pubmed.ncbi.nlm.nih.gov/37704315/Juhani Knuuti, William Wijns, Antti Saraste...
https://pubmed.ncbi.nlm.nih.gov/31504439/Nathaniel R Smilowitz, Megha Prasad, R Jay Widmer...
https://pubmed.ncbi.nlm.nih.gov/37704316/Baylor Research Institute
Lead Sponsor